Singapore markets closed

Celestica Inc. (CLS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
13.20+0.07 (+0.53%)
At close: 04:00PM EST
13.01 -0.19 (-1.44%)
After hours: 04:41PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 1.60B
Enterprise value 2.03B
Trailing P/E 12.16
Forward P/E 6.45
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)0.24
Price/book (mrq)1.02
Enterprise value/revenue 0.30
Enterprise value/EBITDA 5.44

Trading information

Stock price history

Beta (5Y monthly) 2.31
52-week change 36.02%
S&P500 52-week change 3-9.85%
52-week high 314.28
52-week low 38.21
50-day moving average 311.57
200-day moving average 310.60

Share statistics

Avg vol (3-month) 3391.94k
Avg vol (10-day) 3540.42k
Shares outstanding 5103.51M
Implied shares outstanding 618.6M
Float 8101.27M
% held by insiders 12.18%
% held by institutions 176.03%
Shares short (12 Jan 2023) 4671.36k
Short ratio (12 Jan 2023) 41.95
Short % of float (12 Jan 2023) 40.66%
Short % of shares outstanding (12 Jan 2023) 40.55%
Shares short (prior month 14 Dec 2022) 4294.47k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 321 Dec 1999

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin 2.01%
Operating margin (ttm)3.72%

Management effectiveness

Return on assets (ttm)3.28%
Return on equity (ttm)9.27%

Income statement

Revenue (ttm)7.25B
Revenue per share (ttm)58.70
Quarterly revenue growth (yoy)35.10%
Gross profit (ttm)636.3M
Net income avi to common (ttm)145.5M
Diluted EPS (ttm)1.09
Quarterly earnings growth (yoy)32.90%

Balance sheet

Total cash (mrq)374.5M
Total cash per share (mrq)3.08
Total debt (mrq)786.1M
Total debt/equity (mrq)46.86
Current ratio (mrq)1.42
Book value per share (mrq)13.80

Cash flow statement

Operating cash flow (ttm)297.9M
Levered free cash flow (ttm)110.24M